GLG News by Ophthalmologists
Request a free trial
August 19, 2008Visian ICL: Premium Channel for the Extremely Nearsighted
Analysis of: Insiders Buy Staar as Lasik Alternate Shows Potential (Update2) | www.bloomberg.com
Author: Mark Packer, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC
The Visian ICL (Implantable Collamer Lens) is an exquisitely precise technology for the correction of high degrees of nearsightedness -- much higher than the reach of laser refractive surgery such as LASIK and PRK. Given the price of the ICL and the intraocular surgey required for its...
July 21, 2008Ultimately, the Patient, Not the Payor, is the Customer
Analysis of: Glaxo Seeks Guidance From Health Systems | online.wsj.com
Author: Mark Packer, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC
"He who pays the fiddler calls the tune." Here's an example of the fiddler pro-actively asking the guy in the room with the deepest pocket what he'd like to hear. If it's not something in the current repertoire, the fiddler seems willing to learn. However, by the time he's got...
July 14, 2008
Avastin is inexpensive for Macular Degeneration therapy
Analysis of: Costly Cancer Drug Offers Hope, but Also a Dilemma | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: Costly Cancer Drug Offers Hope, but Also a Dilemma | www.nytimes.com
Author: GLG Expert Contributor
I and many other ophthalmologists around the country use Avastin intravitreally for wet macular degeneration in doses far smaller than those used for systemic cancer. Although it is an "off-label" use of the drug, the cost for using Avastin is 1/6oth of Lucentis, a very similar...
June 20, 2008
1st Chartless office in Tenn.
Analysis of: Most Doctors Aren’t Using Electronic Health Records | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: Most Doctors Aren’t Using Electronic Health Records | www.nytimes.com
Author: GLG Expert Contributor
I HAD THE 2ND CHARTLESS OFFICE IN THE SOUTHEAST THE 1ST IN TN. WHEN I 1ST OPENED MY OFFICE IN NASHVILLE IN 1991. ONCE IN YOU CAN NEVER GO BACK TO CHARTS; HOWEVER, THE COST ARE HIGH AND THE LEARNING CURVE IS SLOW. MOST DOC'S DON'T LIKE A CHANGE. THUS THE CONVERSION RATE WILL BE HIGHER IN DOCS STARTING...
June 5, 2008
This should be a significant advance.
Analysis of: Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA | www.cltoday.com
Author: GLG Expert Contributor
Analysis of: Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA | www.cltoday.com
Author: GLG Expert Contributor
This new lens represents a marriage of two important technologies in modern contact lens use; oxygen trasmissibility and convenience in wearing. This has the potential to become a significant portion of the contact lens market.
June 5, 2008
Contaminated solutions or sterile, your choice.
Analysis of: Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA | www.cltoday.com
Author: GLG Expert Contributor
Analysis of: Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA | www.cltoday.com
Author: GLG Expert Contributor
Daily wear contacts reduce the frequency of ocular infection. Contact lens solutions and cases are breeding grounds for bacteria. If canditates, all patients desirous of contacts are advised to wear daily wear disposible lenses.
June 5, 2008
Implications for Astigmatism
Analysis of: Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA | www.cltoday.com
Author: GLG Expert Contributor
Analysis of: Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA | www.cltoday.com
Author: GLG Expert Contributor
Many patients who have irregular astigmatism will find a disposable silicone hydrogel lens to provide good vision with less irritation of the cornea due to protein build up in the lens. This could be a big help to those who may not be LASIK candidates or who are awaiting future Custom LASIK surgery...
May 14, 2008
Laser Refractive Surgery is Here to Stay
Analysis of: LASIK Worries? Some May See Better with Alternatives | www.washingtonpost.com
Author: GLG Expert Contributor
Analysis of: LASIK Worries? Some May See Better with Alternatives | www.washingtonpost.com
Author: GLG Expert Contributor
Although the lask procedure as the primary method of keratorefractive surery has been under scrutiny recently it remains the mainstay of refractive surgery. With a 95% approval it is difficult to critisize its effectiveness. However the 5% patient complaints must be addressed. The risk of...
May 14, 2008
You Don't Have to Fear Discrimination Based on Your Genes
Analysis of: Experts see boost to genetic testing from US bill | www.reuters.com
Author: GLG Expert Contributor
Analysis of: Experts see boost to genetic testing from US bill | www.reuters.com
Author: GLG Expert Contributor
The Genetic Information Nondiscrimination Act (GINA), which will soon become law, will protect Americans who choose to have genetic testing against the fear of discrimination by employers and health insurers. The idea of personalized medicine can not become a reality with out the passage of GINA.
May 7, 2008
LASIK IS AN EXCELLENT PROCEDURE FOR THE APPROPRIATE CANDIDATES
Analysis of: LASIK Worries? Some May See Better with Alternatives | www.washingtonpost.com
Author: GLG Expert Contributor
Analysis of: LASIK Worries? Some May See Better with Alternatives | www.washingtonpost.com
Author: GLG Expert Contributor
The FDA report and scrutiny of LASIK complaints reveals what consientious LASIK surgeons have known for years: Not everyone who walks through your doors is a good lasik candidate and you should not laser everyone. About 1 out of 4 patients that consider lasik are actually good candidates...
Page : 1 2 3 4 5 6 7 8 9 10 Next1 to 10 of 156
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
FDA Alert: Hemorrhagic or Necrotizing Pancreatitis in Patients Taking Byetta
www.fda.gov
Healthways' Guidance Not So Healthy
www.forbes.com
Drug Makers’ Push Leads to Cancer Vaccines’ Fast Rise
www.nytimes.com
Hospital Death Rates Unveiled for First-Time Comparison
www.usatoday.com
Temozolomide And Thalidomide Combination Effective Against Malignant Melanoma Spread To CNS And White Blood Cell Count May Be Prognostic
www.medicalnewstoday.com
Dangers of Methadone Usage
August 28, 2008
Its all about the spin
August 21, 2008
Byetta sale will reduce after FAD alert
August 19, 2008
PCI numbers will not drop after Courage
August 19, 2008
Bad News (but not new news) for stents.
August 19, 2008

